22nd Century Group Inc XXII:NASDAQ

Last Price$1.71Cboe Previous Close - Real-Time Last Sale as of 3:59PM ET 8/16/22
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$1.68 (1,000)
Ask (Size)$1.71 (100)
Day Low / HighN/A - N/A
Volume2.6 K

View Biotechnology IndustryPeer Comparison as of 08/16/2022


22nd Century Group Inc ( NASDAQ )

Price: $1.71
Change: +0.01 (0.59%)
Volume: 2.6 K
3:59PM ET 8/16/2022

Selecta Biosciences Inc ( NASDAQ )

Price: $2.45
Change: +0.01 (0.41%)
Volume: 328.00
3:59PM ET 8/16/2022

VBI Vaccines Inc ( NASDAQ )

Price: $1.29
Change: -0.01 (0.77%)
Volume: 9.2 K
3:59PM ET 8/16/2022

Cymabay Therapeutics Inc ( NASDAQ )

Price: $3.91
Change: -0.005 (0.13%)
Volume: 630.00
3:59PM ET 8/16/2022

Alaunos Therapeutics Inc ( NASDAQ )

Price: $1.85
Change: -0.10 (5.13%)
Volume: 10.5 K
4:00PM ET 8/16/2022

Read more news Recent News

22nd Century Group Q2 Net Loss Widens, Revenue Advances
6:21AM ET 8/09/2022 MT Newswires

22nd Century Group (XXII) reported a Q2 net loss Tuesday of $0.06 per diluted share, widening from a $0.03 loss a year earlier. Analysts polled by Capital...

-- Earnings Flash (XXII) 22ND CENTURY GROUP Reports Q2 Revenue $14.5M
6:00AM ET 8/09/2022 MT Newswires


-- Earnings Flash (XXII) 22ND CENTURY GROUP Reports Q2 Loss $-0.06
6:00AM ET 8/09/2022 MT Newswires


--Alliance Global Initiates 22nd Century Group at Buy With $5 Price Target
12:32PM ET 7/21/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business Description22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions the for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY. View company web site for more details
Address500 Seneca Street
Buffalo, New York 14204
Number of Employees82
Recent SEC Filing08/09/202210-Q
Chief Executive Officer & DirectorJames A Mish
President & Chief Operating OfficerMichael J. Zercher
Chief Financial OfficerRobert Hugh Kinsman
Vice President-Research & DevelopmentJuan Sanchez Tamburrino

Company Highlights

Price Open$1.74
Previous Close$1.70
52 Week Range$1.42 - 4.05
Market Capitalization$367.3 M
Shares Outstanding214.8 M
SectorHealth Technology
Next Earnings Announcement11/03/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.22
Beta vs. S&P 500N/A
Revenue$26.4 M
Net Profit Margin-111.52%
Return on Equity-57.95%

Analyst Ratings as of 07/20/2022

Consensus RecommendationConsensus Icon
Powered by Factset